Posted by Michael Wonder on 14 May 2020
OIA response: effect of COVID-19 on medicine supply
14 May 2020 - PHARMAC responds to OIA request by releasing a raft of documents.
The documents indicate that COVID-19 is likely to have global impacts on medicine manufacture and supply chains for the remainder of 2020 and potentially beyond.
PHARMAC is actively engaging with suppliers about contingency plans and will continue to update our website with information as the situation evolves.
